Krystal Biotech, Inc.SEC Filings
|
|
All SEC filings by Krystal Biotech, Inc. (KRYS) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Aug 3, 2026 | |
| 10-Q | Quarterly report | View Diff | May 4, 2026 | |
| ARS | Annual report to shareholders | Apr 3, 2026 | ||
| 10-K | Annual report | View Diff | Feb 17, 2026 | |
| 10-Q | Quarterly report | View Diff | Nov 3, 2025 | |
| 10-Q | Quarterly report | View Diff | Aug 4, 2025 | |
| 10-Q | Quarterly report | View Diff | May 6, 2025 | |
| ARS | Annual report to shareholders | Apr 3, 2025 | ||
| 10-K | Annual report | View Diff | Feb 19, 2025 | |
| 10-Q | Quarterly report | View Diff | Nov 4, 2024 |
Events
| 8-K | Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results | Aug 3, 2026 | ||
| 8-K | Other Events | Jul 21, 2026 | ||
| 8-K | Submission of Matters to a Vote of Security Holders | May 19, 2026 | ||
| 8-K | Krystal Biotech Announces First Quarter 2026 Financial and Operating Results | May 4, 2026 | ||
| 8-K | Krystal Biotech Announces Fourth Quarter and Full Year 2025 | Feb 17, 2026 | ||
| 8-K | Krystal Biotech Provides Business Update at 44th Annual J.p. Morgan Healthcare Conference | Jan 12, 2026 | ||
| 8-K | Regulation Fd Disclosure | Jan 8, 2026 | ||
| 8-K | Departure of Directors or Certain Officers | Dec 23, 2025 | ||
| 8-K | Krystal Biotech Announces Third Quarter 2025 | Nov 3, 2025 | ||
| 8-K | Other Events | Oct 22, 2025 |
Registrations and Prospectuses
| S-8 | Registration of securities for employees | Feb 26, 2024 | ||
| S-3ASR | Automatic shelf registration | Jul 18, 2023 | ||
| 424B5 | Prospectus supplement for primary offering | May 8, 2023 | ||
| S-3ASR | Automatic shelf registration | Apr 6, 2023 | ||
| S-8 | Registration of securities for employees | Feb 2, 2023 | ||
| S-8 | Registration of securities for employees | Feb 17, 2022 | ||
| 424B2 | Prospectus for primary offering | Dec 1, 2021 | ||
| 424B5 | Prospectus supplement for primary offering | Nov 29, 2021 | ||
| 424B2 | Prospectus for primary offering | Feb 4, 2021 | ||
| 424B5 | Prospectus supplement for primary offering | Feb 2, 2021 |
Proxies
| DEFA14A | Additional proxy soliciting materials | Apr 3, 2026 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 3, 2026 | |
| DEFA14A | Additional proxy soliciting materials | Apr 3, 2025 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 3, 2025 | |
| DEFA14A | Additional proxy soliciting materials | Apr 4, 2024 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 4, 2024 | |
| DEFA14A | Additional proxy soliciting materials | Apr 4, 2023 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 4, 2023 | |
| DEFA14A | Additional proxy soliciting materials | Apr 7, 2022 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 7, 2022 |
Other
| UPLOAD | Letter from SEC | Apr 24, 2023 | ||
| CORRESP | Correspondence with SEC | Apr 11, 2023 | ||
| UPLOAD | Letter from SEC | Mar 30, 2023 | ||
| EFFECT | Notice of effectiveness | Oct 15, 2018 | ||
| UPLOAD | Letter from SEC | Oct 10, 2018 | ||
| CORRESP | Correspondence with SEC | Oct 9, 2018 | ||
| EFFECT | Notice of effectiveness | Sep 19, 2017 | ||
| CORRESP | Correspondence with SEC | Sep 15, 2017 | ||
| CORRESP | Correspondence with SEC | Sep 15, 2017 | ||
| CORRESP | Correspondence with SEC | Sep 7, 2017 |
Ownership
| 4 | Krishnan Suma | Sep 4, 2026 | ||
| 4 | Krishnan Krish S | Sep 4, 2026 | ||
| 144 | Notice of proposed sale of securities | Sep 4, 2026 | ||
| 144 | Notice of proposed sale of securities | Sep 4, 2026 | ||
| 4 | Rossi Dino A | Aug 14, 2026 | ||
| 144 | Notice of proposed sale of securities | Aug 14, 2026 | ||
| 4 | Thomas John Charles | Jun 26, 2026 | ||
| 144 | Notice of proposed sale of securities | Jun 25, 2026 | ||
| 4 | Krishnan Suma | Jun 5, 2026 | ||
| 4 | Krishnan Krish S | Jun 5, 2026 |